Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy
Clinical trial NCT01215097 · COMPLETED
Trial details
- NCT number
- NCT01215097
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-04-01
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.